Google TrendANNA BONDAR (200+) — October 11, 2026: Lilli Tagger vs Nikola Bartunkova: Set 1 Winner Prediction Market
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "World's First Patient Tre" (30 stories)

Top Headline Story

FDA Grants Clearance to Motivista, the First Authorized Treatment for Negative Symptoms of Schizophrenia
Lead StoryPsychiatric Timesgeneral
3d ago

FDA Grants Clearance to Motivista, the First Authorized Treatment for Negative Symptoms of Schizophrenia

<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxNZTJfUHFFYlgtYkpVZ1BaaVNkaHZKdGRrakJoTVIwUFBDcXBPdlk4a2ZodXJVdVlybGFvU2dCNlE1MFVyUWU3N3BRMExDLXhFN2dXNHNNRTBvenFBUHRHOV8zOEh2d3M1QzdKV0FXTXZCUkZnRFFOWl9ILWFxVGxOZEVuM3NuN1pqeE4yVjVtb0FYN3JPQTdINjZDNWw5OWxLd21fMFQ2Ukc2cEhtSU96c0RRLWhQRW5VckVxREV4QmlveHlPVUswMkVNT2FKU2l3ZXRxY2E2TnA?oc=5" target="_blank">FDA Grants Clearance to Motivista, the First Authorized Treatment for Negative Symptoms of Schizophrenia</a>  <font color="#6f6f6f">Psychiatric Times</font>

Real-time search volume
200+15m ago

anna bondar

October 11, 2026: Lilli Tagger vs Nikola Bartunkova: Set 1 Winner Prediction Market

100+15m ago

natanael cano

Padres de Natanael Cano rompen el silencio tras retiro del cantante: "Es por el bien de nuestro hijo"

500+25m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

10000+25m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

Search Results for "World's First Patient Tre"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Teenager becomes first person to have testicular tissue transplant in UK
The Guardiangeneral

Teenager becomes first person to have testicular tissue transplant in UK

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxPRGJtaUp0LWNLSUF6UGdhSjV4cFJQb3NxVGtkTF85dHpzOW1XVTlvWE95b2lpdm1rb3RKXzhEeWdJbFQwUksyeWk0WE9KT2tkeHVQZzBfSVExVVU1cjNFcjVBTVhFLTB6ek1BclpMLUdHSVFpNkp3VTcxQzU5ZkFHdmJXUGNTN2lySXJMYVk0TGl3VGJ0UVpTRFo5M2R6bFNxRkloMWdUYTh0WVZXajZ0Z3NxOFJrQ0JsZnJrdUhUQ2ltYVNGbWE1dUJVcw?oc=5" target="_blank">Teenager becomes first person to have testicular tissue transplant in UK</a>  <font color="#6f6f6f">The Guardian</font>

Lilly's Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLL
PR Newswiretech

Lilly's Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLL

<a href="https://news.google.com/rss/articles/CBMi1gJBVV95cUxQTDIyX2I0VERham8wN00yWXNoNG1RVWNOOWpHM1VzUHV5Z3hNSWZtTmlsWFZ4bVpaaXlKb3VrNnBkMm04QXJwaFhsU2ZWTFdqRlNyZVFCU3JhWGExVkJxUWozS0tKUjVZaFNPbFR1RHlpZzI3MlBYa2FyY2JVZVZpOVEzVThHMGJKbXFXR2tMWmJZRFhvdjFnWFZhNGI0OWIyZDlXbGJwWXVSS0RySHN0OEF0eUxLbWJaeUhXUk54TGFxMmVyaGxjeXlOQ2gzbVd3SFB5a3Z2WHN4UF9RYzJCVmZibmgwU3gwdVVaT2lDVWF0TnNNZFBMLUJvcE1OUXZVNlJxQlVTU2hPRWQtTGRXd2p1VTBtQUtmUjZlOTNpSEo4d0JjbUVRR0FhM0d3SkR5UjRLQ0o4WDhMZFZfMTE1OEt3TDNfbTVfdTVBQThaNmRpREJKYWc?oc=5" target="_blank">Lilly's Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLL</a>  <font color="#6f6f6f">PR Newswire</font>

EyeWorld Weekly, September 25, 2026
EyeWorldworld

EyeWorld Weekly, September 25, 2026

<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE5HYXlnWTZ2QlBDd0k4N0hmYjVnZUJPOGlkb3JLQkVxcVMxQzhpRkVBTHN4dmJtQkdQOWZPMkMtOGVxQjZRTWxiQkw5WExDdzctYmQzVDJnYzR0aE9FUlVnX0cxeG1nekdMZFRscEN4Rks5UQ?oc=5" target="_blank">EyeWorld Weekly, September 25, 2026</a>  <font color="#6f6f6f">EyeWorld</font>

Lubbock patient is among the first in West Texas to receive non-invasive liver cancer treatment
KCBDgeneral

Lubbock patient is among the first in West Texas to receive non-invasive liver cancer treatment

<a href="https://news.google.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?oc=5" target="_blank">Lubbock patient is among the first in West Texas to receive non-invasive liver cancer treatment</a>  <font color="#6f6f6f">KCBD</font>

First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon Cancer
The Manila Timesgeneral

First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon Cancer

<a href="https://news.google.com/rss/articles/CBMi-gFBVV95cUxPR25kYkJieVdIOWxOcXl2aks4aU1QQXlfenNCN2Z4WHlyaGhfOWh3OEhfdWRvbHpYMThXRTh6cjBEMzYyV2NzMlY4R3E5Y0tDV2gtTkJCb3FlUDdabjRrQWxxaUxuN2RWbXRWM0R0YUNPN2ZqVG5UX3F1bVVzR0hpanNLWkZJVGl1by1CYjREUVZEQy1YZ3ZRbE5sTmpWTklmQ3RSTlRick9UX1BTR01HcnBGMnBLc280MU13MV81RzhOZ3lqZ3hsZk82ZWt1S0VLOW9sNG5UdTcyZ3lqVWpick9sZDBRLVFBb01Ob2NVcnlySDNLUDh6c1p30gH_AUFVX3lxTE10SVdsSEpCdndGYXdtLW1UQkFjNmVjTjkwTTQ0ZGFmRkRzSjFaT2Zkb0pnNDZKXzZJYnhveU0zQ1NEQXJPSUM5UDlGVFhlaGxtSGJBQVk3R0lUQ1JNdWhIUmI2QkkzZ2J0aE81NlhUZXhyOW0yYXhDb01pdU8zalBXeC0xXzJNY255OEF2Tk81R0VYNkpaSVNsRkpicXgwd0N4Vm8yYWtyVTMyUDB4enpGcnFBWXNXSUU4bDlzQVROWk45S0V0Ny1aR0lSN1BPcHpaZEtaYm9ReEtnNFFzVzl0Zm9oLXQ0VnpvUjZlTkR0eE1idllSM2tWTUJGVk8yTQ?oc=5" target="_blank">First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon Cancer</a>  <font color="#6f6f6f">The Manila Times</font>

Pancreatic cancer: Gemelli Hospital performs world’s first treatment using radioactive glue
Il Sole 24 OREworld

Pancreatic cancer: Gemelli Hospital performs world’s first treatment using radioactive glue

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxONXJIWlhDYzdyRmYxVGstdlBkV1dScWt6N2Zqa0dmZXk0YXJxTEZWUFVkNkhNNU5ScUt1U3ctdXBmQ1lDS3c5Y0pSdC1CVVBIaDI2Z1QzSDk2ekZUdUc3OUxEcEVxSEZoOWJRZWpPbmpkQWxZTExwRkQwRjRscUhvcVJGWG9pZmFqZUg3anFkR1hkVVVlSDhCOUV4dDRJU1pwcDZSTGMxNkllaFhMNldCbnV3?oc=5" target="_blank">Pancreatic cancer: Gemelli Hospital performs world’s first treatment using radioactive glue</a>  <font color="#6f6f6f">Il Sole 24 ORE</font>

The Moment a New Cancer Treatment Met Its First Patient
Singapore Economic Development Board (EDB)general

The Moment a New Cancer Treatment Met Its First Patient

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPTlVNQWdZWTFteWxpVWFpdUZHcHhZajNvd2hIZ2hWSkt1TFJ0VTUyS29yM1hKN0V5eHdPVFpPdjkyZlo3LUo2UXpPRFRmVDNha1VBOERxRkppOTkwcFRyU2l1OTNOZkhwZ1BMTlNhN1NWSFBHbW1aa0dPSTYwNTM5cVZwdlZxaXJrTXdSWmNvRUd1ejVSclF0cmg5Z08?oc=5" target="_blank">The Moment a New Cancer Treatment Met Its First Patient</a>  <font color="#6f6f6f">Singapore Economic Development Board (EDB)</font>

Veteran becomes first VA patient to undergo groundbreaking epilepsy treatment
VA News (.gov)world

Veteran becomes first VA patient to undergo groundbreaking epilepsy treatment

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxNaDFGY09Sc1Rpb2o2STVja0tJZnZSQjJkS3JVd0RILUhSZ2wwZmc5UWttTGR4RXRnNVNmanFaRTdmN1BXRHA5MnZBOEJuTnhaUXZkdFpUaWFOOFk2WU84RlpkYzFoZ2x2dWpOaDlkUlduU1JCQ2ZCSnNhQ1JzcmQ1SA?oc=5" target="_blank">Veteran becomes first VA patient to undergo groundbreaking epilepsy treatment</a>  <font color="#6f6f6f">VA News (.gov)</font>

A Hopeless Diagnosis? Not for This Patient.
The New York Timesgeneral

A Hopeless Diagnosis? Not for This Patient.

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPVUtXVjMwMjJWUktXQXc5cWlKckZOenE5bklmS0hyTXJGMUZDOXhfdGZRNUhlakc0SW9Oc2pPM01LNHRFb2hBRVkzQTFvMnJrT1FrMU44Y0hHNWV6Tlg3OGxiMlA5ZExzN0VmY28wSC1oZXh0WDZXanBBeG00STEwajYxbVRITzVQN1BSSEk2UGJ3UQ?oc=5" target="_blank">A Hopeless Diagnosis? Not for This Patient.</a>  <font color="#6f6f6f">The New York Times</font>

7-year-old is the first to receive proton therapy at Stanford Medicine
Stanford Medicinegeneral

7-year-old is the first to receive proton therapy at Stanford Medicine

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTFBvWFlEdFV1Wm1mdnVuX1RSeExDNmo1TGk0SUJPcGhNWks0WHJNeXRlRElCLWYyeEp6RDVNaUlxTlpiS3BmU1hZX19OU2tscjQ5VTI2Skg3M29VWmVKMktHRk9ncXhXNU1LRmR3Q0JoYW9DWW45?oc=5" target="_blank">7-year-old is the first to receive proton therapy at Stanford Medicine</a>  <font color="#6f6f6f">Stanford Medicine</font>

Deaf Toddler Undergoes First-of-Its-Kind Gene Therapy Treatment in the US to Gain Hearing
People.comtech

Deaf Toddler Undergoes First-of-Its-Kind Gene Therapy Treatment in the US to Gain Hearing

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxQRExyNkVHaGxVMl9iNWJHb1Z5RkV0Xzl4Vi1ncXZGVjBqVDFpSnhESmJ5ZzZXdFFkc0xsSDFwQ3Fia0ZNVldOMWZEajdTZjFaUVZCamliajB0ZktvNmh1NS1RQmdnTmM1NHlEMmgwa0ozVi1jbjE4OW53bFNxdkt6VmQ3dXRlWDRhQ2c?oc=5" target="_blank">Deaf Toddler Undergoes First-of-Its-Kind Gene Therapy Treatment in the US to Gain Hearing</a>  <font color="#6f6f6f">People.com</font>

A new treatment at Boston Children’s Hospital, the first of its kind in US, offers hope for children born deaf
The Boston Globegeneral

A new treatment at Boston Children’s Hospital, the first of its kind in US, offers hope for children born deaf

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxNR3V6VnVZYS1ZeEo4enlIZkFZTGpUb25MeHFoTjZWVlBvU1BZeHNCU3BuLU11Tnl2ZlZVZ1pJRHlMMlFFelEyNFBTOEl3R2tqQ29DUVcyY2pxSE5DajhOT2czeUlxaWJNZHFtWktwaVdMcWtpcXcxYlFTbkVVYUZpeFdR?oc=5" target="_blank">A new treatment at Boston Children’s Hospital, the first of its kind in US, offers hope for children born deaf</a>  <font color="#6f6f6f">The Boston Globe</font>

Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies
Life Biosciencesscience

Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPLTdKVldSdHRjZVJSVFM1X2ZTWG1FcFRwc05UVnh0eGhtbWtISGNLU2xGTmFNWTlJOThVcWpFMGkzREFxU2IyTDQxV3ZNbkJkMEU5VVU0Ny1QY1RwVzFJSFVTWmtkazZwUUZQV3owVlBYSmFGTzhlYUpWdEU5QXZ2UVdFME1iTV9pcVZ1UjdOQ0k3Q3J3UFJ6bGxack5WLTlvQjdHWW5NM0pFemFoNFMyQVFwXzNQSGFpdWNjMHpBX01uUmVmcEllTw?oc=5" target="_blank">Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies</a>  <font color="#6f6f6f">Life Biosciences</font>

Pediatric CAR-T therapy, a breakthrough cancer treatment, is a "Philadelphia story all the way," CHOP says
CBS Newsgeneral

Pediatric CAR-T therapy, a breakthrough cancer treatment, is a "Philadelphia story all the way," CHOP says

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPdFVYZ3c3b3BoZ3F3MXBwNUl5TVNrOUpoTjJmS3hwVTIzNW10VUxraXdraGdWSjNjdFRFLVZETWRaMzhkMUt0MUVwc1pSS0lackc0cDItd240cjBvVng4cWl2Q2ZrNEpDUkpNTzJKaDJNQThxN1BtOWtJTHUxM3l2eFJaM1g4Mi1TdWRKUzBKQ0FXbWdvQXZSQkJ4MFE4bE1CTGp1dlU0OV8?oc=5" target="_blank">Pediatric CAR-T therapy, a breakthrough cancer treatment, is a "Philadelphia story all the way," CHOP says</a>  <font color="#6f6f6f">CBS News</font>

First patient receives innovative new treatment after stage 4 cancer diagnosis
Loma Linda Universitygeneral

First patient receives innovative new treatment after stage 4 cancer diagnosis

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNMThuU0wta1lCaTRJdHNpckNHQjRLTFZLdjZvUWJEWW02d2FxbVBBYm1vLU40RGxYSUxGNUh4MU5CQWJWTUR5SDNoTmE0ZjhFOTVsamhheUdjd1ZpSmhkbzBDS3ZHUkowaXRCVV94cW80MFlQcENyWm11NS1IZVBYQ2pESmQ0WVNlR3VaLTlRbnpXQ01aQ3lvclZ6c0N3SzRZQjhfUjRGdkNfZFU4N1pJTFBB?oc=5" target="_blank">First patient receives innovative new treatment after stage 4 cancer diagnosis</a>  <font color="#6f6f6f">Loma Linda University</font>

Matthew Rhys Makes Emmy History as First Person to Win Two Lead Acting Emmys in One Night and First Man to Win All Three Top Acting Prizes
Varietygeneral

Matthew Rhys Makes Emmy History as First Person to Win Two Lead Acting Emmys in One Night and First Man to Win All Three Top Acting Prizes

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQamxDLVQ5dFlkVG1LZUVZUHR4WF9KXzBWdlFqMXJNMVYyZjBZcWRGVGxOYi1WUE9yaU1idEdEOVJvZVVkUGc0MEFFS05keHhMVGltWld2QlQySnhud2J4RF9HY1QwRVZVYW9lTHBQbGRYaV83QTRBblRmMEx5YW5CdU1BZ3IxdTdOMDZPbmUwYUIyNXNGSGVoRw?oc=5" target="_blank">Matthew Rhys Makes Emmy History as First Person to Win Two Lead Acting Emmys in One Night and First Man to Win All Three Top Acting Prizes</a>  <font color="#6f6f6f">Variety</font>

TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)
IONISgeneral

TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNZnZJdVVDRzY0TmVWaVVRWkxmekN2SkhQRFlMNU1Zd3FaZzNfQmpBSGFxTVJ3SzBMQjQyOHhNaU1BbmNXLTc2eG0wcFg5d0tLOVdtV29oeVJvS3JUY2x3aVVjc0FHem8ta21hbHJPbkJGNFZtTllXVDJETng0SGVMMkhrY2xHanBEcjMyb1BGckdheWRpQ1p4Q29PZ2sxNFFpR195Rno1eXRtaFpHTmNKblQyaXQ?oc=5" target="_blank">TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)</a>  <font color="#6f6f6f">IONIS</font>

World-first: therapy to make cells young again trialled in a person
Naturetech

World-first: therapy to make cells young again trialled in a person

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE51WVctZDkxRk9LX1dKbU95OGRVQUdJWUxPQ1dGaVFmM2NaLWFSYk92UTlUNGhZTklSeG85QVdnQVZnRDhZdVQyVXVKdGJ6RmIwMDdjT1hPQkFyb2pYMVVz?oc=5" target="_blank">World-first: therapy to make cells young again trialled in a person</a>  <font color="#6f6f6f">Nature</font>

A first in the Gulf South: Tulane doctor helps to 'functionally cure' sickle cell patient
Tulane University Newsworld

A first in the Gulf South: Tulane doctor helps to 'functionally cure' sickle cell patient

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQVGZ5bjZhUjFlQjJXUU9iTjhSZ1FhMjdGdXMzR21LeURpNTExY2EwUGxFSjNmQjlkZ3h5eDZNUUs2Ti1FVmROcm1qLXRSMm9QTTZxNE85N3Zhdm5UdDVRUFkxNjZ0WnZVc0tFSUl5TFZDLVN0NllWNDc5UklqUVV6cEVnb1hIZU1QRC1rY1BRaXM4eUZsZGc4TlF2NGRxNzZDMmFHRnc5Unhhdw?oc=5" target="_blank">A first in the Gulf South: Tulane doctor helps to 'functionally cure' sickle cell patient</a>  <font color="#6f6f6f">Tulane University News</font>

Hadassah hospital performs first-ever experimental treatment for brain cancer
The Jerusalem Posttech

Hadassah hospital performs first-ever experimental treatment for brain cancer

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5xc0FvZ2RZV0g3RGliZkFOTjhGLWRzUmpyQ0ZjYktiWVVzVEZxX0wzN2FsNUR3aWdhVTFzclBBWk5SZnFRZ3hMYUR0V0NxcEd6dzRsMTRCS1VucHd5Rm1qT2xZLUtQRFE?oc=5" target="_blank">Hadassah hospital performs first-ever experimental treatment for brain cancer</a>  <font color="#6f6f6f">The Jerusalem Post</font>

Oldham woman becomes world's first to receive new cancer therapy
BBCworld

Oldham woman becomes world's first to receive new cancer therapy

<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE5xZEtKYjcwWjJLWDdtTnlYZ2VIZ05aYUpVdlZpQjBLdUs1QVJHZklTTXFxSXBSNzZSUmxaSF81OTRrU2RYdXBMMWhpcERUTXdZZWVwM2JaLVNSZw?oc=5" target="_blank">Oldham woman becomes world's first to receive new cancer therapy</a>  <font color="#6f6f6f">BBC</font>

OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors
PR Newswireworld

OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors

<a href="https://news.google.com/rss/articles/CBMigwJBVV95cUxOV0VtdU1PbmxZNnBfckNxU0ZjbGc3RkZkcmY2ZFBQYjJCaTdfOVFLcmRyempYa1l0WVRVZ1M1NVhmM0VXMGxjOTRsWS1OcWJ3WWxoWllXU09uczBVR09NaDBhcm9oYmFSbWV4NkxUVjhRalNINUhvQUlkNmZaSlItbkd3UjVMTUNzeXZfTmJiekZuaTRUQ3pmREJZTVgtX1Y1NDJueEhaMzVLcjZwQnVjd2xJdl9fSl8wVjBPa3FQd3JiYlFRMnJaVllJVnhZNk9xYVBlR3pJZ1BmVGJKT2N5MTNIS3I3cXpsd3l0QkNGMGphUDRVbDlCOUhOZ3cxLW0zSXRR?oc=5" target="_blank">OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors</a>  <font color="#6f6f6f">PR Newswire</font>

World's first WWOX gene therapy performed on infant in Israel
The Jerusalem Postworld

World's first WWOX gene therapy performed on infant in Israel

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBrdWowRzZSVllzQ1piUC1IdjRYdWxjUWtlbmxsY1NJNUFpUk9Dak1UZndDZkpLMTNkQXY3N3gxSDU2eWFNTWdpQXJtTlVBSHRvVEdVT0l0TlR3dE1UMFIwdnc1b2kwUlk?oc=5" target="_blank">World's first WWOX gene therapy performed on infant in Israel</a>  <font color="#6f6f6f">The Jerusalem Post</font>

Patient enrolment begins in a scientific trial to identify the first effective treatments for Bundibugyo virus disease
World Health Organization (WHO)world

Patient enrolment begins in a scientific trial to identify the first effective treatments for Bundibugyo virus disease

<a href="https://news.google.com/rss/articles/CBMi8AFBVV95cUxPSlFPY0ZQUXlVWWl2aDBVeU9rdWdISjRBUnRtaEV3MGR0R05fTmFORjV6cnJTbzBUZkEtSk92R1dYWmNJTVpMd1dFbENOMVhLVmdJUktHQklpSWFJbkMxbEdPeTlqNVJCZnlrcURlZURHLUtrb2NLMl9NaW5weFVxdUFaeHBkcEh0QTlZU3hoTS1nQjcyeVhmNm96SFJydzNZaGtXVE5nR2lwZjh1amlycFlKNU05NVpQSWxoLWU2b1ExUXhXNFpDTVJqejRUUVRjS0tSVF9uSG1zdHBtLUlaMW9aTDNQUlJLWS1XMHVlQWQ?oc=5" target="_blank">Patient enrolment begins in a scientific trial to identify the first effective treatments for Bundibugyo virus disease</a>  <font color="#6f6f6f">World Health Organization (WHO)</font>

First Huntington’s Disease Patient Dosed with Neural Stem Cell Therapy
Inside Precision Medicineworld

First Huntington’s Disease Patient Dosed with Neural Stem Cell Therapy

<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxNYkh4TW8tX0NjME5oZjZRYVhPNDJpTjUxRlVHbmJYQnlkVVBydXBRQXpCQjJ2QkswMndBa0FkMTlFamdBOWVoQTVEeEg5WTc1cm1sZDdhQnNFOXRjODN1WVJOTjVmTy0zckxjZmxUVEpJU3V2X3R1OGtGZWtqNUhFaVMzVGNETzRieDhYZk5xZU9WcHk5RnZSUW5LbFB1bWlqQ0F0WGdodTd2clNuQzVPNFc2a3NlRjlaZ2l3TzN1QnBMa0NCNEc1eWp3eFRZcHNZS2c?oc=5" target="_blank">First Huntington’s Disease Patient Dosed with Neural Stem Cell Therapy</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Through sheer determination, Neena Nizar has become the first patient in a clinical trial testing a treatment for Jansen’s disease, a rare disorder that deforms bones. Her disease affects just 30 people worldwide. https://nyti.ms/4gf1mmv
Facebookworld

Through sheer determination, Neena Nizar has become the first patient in a clinical trial testing a treatment for Jansen’s disease, a rare disorder that deforms bones. Her disease affects just 30 people worldwide. https://nyti.ms/4gf1mmv

<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxPQ3licDM3anhoWVg4Y1BCM0J2cXAxRDVlbUw0OGxmUFVvaFg5em94TGRHanVXS2htSlVHWUdJWlVpaUNHWlVWZWQwUjN5c0xhNDZGc1hOQnRDTG5WZEhxeDNMc0NYemFQQnlFenhMdVVwVi1qMXdoRkJlOEg3Z0J2MGlZZUFvelo1a3VDNWYzUS01Qmc4VWQ5ZmVGSjVkWjd0Z09nNmVGb0ZpMGNZQi1wQ3lWcUJPWjRwTk43Qld6YTJMTjl1c3ZTdm5pUDdnMG1lUDNz?oc=5" target="_blank">Through sheer determination, Neena Nizar has become the first patient in a clinical trial testing a treatment for Jansen’s disease, a rare disorder that deforms bones. Her disease affects just 30 people worldwide. https://nyti.ms/4gf1mmv</a>  <font color="#6f6f6f">Facebook</font>

Servier Announces First Patient Enrolled in Phase Ib/II Study for the Treatment of a Rare Pediatric Epilepsy Syndrome in the U.S.
PR Newswireworld

Servier Announces First Patient Enrolled in Phase Ib/II Study for the Treatment of a Rare Pediatric Epilepsy Syndrome in the U.S.

<a href="https://news.google.com/rss/articles/CBMijwJBVV95cUxPN2hqNlNmaFVNaE5ZZXFsQjREUzRERTh0U1hYSlBpdUdoTVFuaTZpX2NaOGl0NmVHcjZQZTcyQjR4YmlmR1gweWk3UC01RXdGNE9Yc0p4NW45WHR0VW9abEYyR2ppMGotSEtIM3haUGg5UHF6MG9uWGx4bXN0bF9wT0UxQVctS280OFJ5UHdKNXdTQ1ozblR3a3hRbzA0YVlQRWh1Y2tHVTVLYVZhZk9OZmh0aWstdVUyb3pJbGoxeFhRcENUN0xwZmZUUWg5RnlsbEtIUTFGNzRNUUtiNzRSQzhXc3dyUjJGM1l2SmJaMjBYbElfM2ZSU3Z2LW1MVVYwTm1YQnRyc1ZESld2akpJ?oc=5" target="_blank">Servier Announces First Patient Enrolled in Phase Ib/II Study for the Treatment of a Rare Pediatric Epilepsy Syndrome in the U.S.</a>  <font color="#6f6f6f">PR Newswire</font>

A baby’s life changed forever by a world-first gene editing treatment
Futura, le média qui explore le mondeworld

A baby’s life changed forever by a world-first gene editing treatment

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQazVkbUJzYlhPZVhrdU5YNllRRktYUWFYNVJ2U2lqRTZqM2NLdEJKRTIxZVQtc3hkR2RieDhPS3ZwMkd0RzMwS3h3Z2UwcUlfM1F2S3Axd2Y1ZC1MNkMzbzdJWjhSTjJSXzRMRXlVRkFFcmIzQ1VGUW9sRjgzUGk5RElkVGZoNFJQaFpTd3dxYnp2ODNxT2lKWVByVEY0MUYyY25WTWN4anhaV1o1U1NF?oc=5" target="_blank">A baby’s life changed forever by a world-first gene editing treatment</a>  <font color="#6f6f6f">Futura, le média qui explore le monde</font>

Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
BioSpacegeneral

Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

<a href="https://news.google.com/rss/articles/CBMioAJBVV95cUxPVnlTdHFQTy1jVjNCS1c3SmlDNjBhSm1QS0IzZHJoZ2ZNeXJqMFZZQUgyWDM5UzF3eUFneG1KY3FHbFVIQm51VkVQQXF0R1FLSHlYUDUxMFJGTzlJVFF0cEJBNUgtbDFVMmZPeGhESXdYYWRDSEJiQTlWVTVBUWlialBJbTN6LVhHeVBkSndHOU9sMzZfcl83anl4TkpTaXc3am9SVnVmb01vTmZNN1lhbmVWWXU3RUVORTh6c0Y3QjV1cG1RQUk4Y3dLTVpyQm50Q19ONkN6QWZJbm1JMTY5UlBNbVVmVkRoTlZkbVd5MHUxczZ1dU9jTzJqcm1oQnFnRS1UU29ib2VLa1FnM3EzekdKS0Z1WnJ1ZlEtbS02MXA?oc=5" target="_blank">Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)</a>  <font color="#6f6f6f">BioSpace</font>

"World's First Patient Tre" — Live Google News Trends & Headlines